Low fucosylation defines the glycocalyx of progenitor cells and melanocytes in the human limbal stem cell niche
- PMID: 39706176
- PMCID: PMC11784483
- DOI: 10.1016/j.stemcr.2024.11.008
Low fucosylation defines the glycocalyx of progenitor cells and melanocytes in the human limbal stem cell niche
Abstract
It is widely recognized that the glycocalyx has significant implications in regulating the self-renewal and differentiation of adult stem cells; however, its composition remains poorly understood. Here, we show that the fucose-binding Aleuria aurantia lectin (AAL) binds differentially to basal cells in the stratified epithelium of the human limbus, hair follicle epithelium, and meibomian gland duct. Using fluorescence-activated cell sorting in combination with single-cell transcriptomics, we find that most epithelial progenitor cells and melanocytes in the limbus display low AAL staining (AALlow) on their cell surface, an attribute that is gradually lost in epithelial cells as they differentiate into mature corneal cells. AALlow epithelial cells were enriched in putative limbal stem cell markers and displayed high clonogenic capacity. Further analyses revealed that AALlow epithelial cells had reduced expression of GDP-mannose-4,6-dehydratase, an enzyme catalyzing the first and limiting step in the de novo biosynthesis of GDP-fucose, and that inhibition of fucosylation using a small-molecule fucose analog stimulated the proliferative potential of limbal epithelial cells ex vivo. These results provide crucial insights into the distinctive composition of the glycocalyx in adult stem cells and underscore the significance of fucose modulation in the therapeutic regeneration of the human limbal stem cell niche.
Keywords: GDP-mannose-4,6-dehydratase; fucosylation; glycocalyx; human limbus; stem cell niche.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests P.A. and A.M.W. declare that a provisional patent application related to the methods and findings described in this manuscript has been filed. The provisional patent application is titled “Fucosylation inhibitors for the treatment of ocular diseases” and was submitted on 03/01/2024.
Figures




References
-
- Bandini G., Haserick J.R., Motari E., Ouologuem D.T., Lourido S., Roos D.S., Costello C.E., Robbins P.W., Samuelson J. O-fucosylated glycoproteins form assemblies in close proximity to the nuclear pore complexes of Toxoplasma gondii. Proc. Natl. Acad. Sci. USA. 2016;113:11567–11572. doi: 10.1073/pnas.1613653113. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical